During the last three months, 13 analysts shared their evaluations of Comerica (NYSE: CMA), revealing diverse outlooks from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 2 | 10 | 1 | 0 |
| Last 30D | 0 | 0 | 1 | 0 | 0 |
| 1M Ago | 0 | 0 | 3 | 0 | 0 |
| 2M Ago | 0 | 0 | 1 | 0 | 0 |
| 3M Ago | 0 | 2 | 5 | 1 | 0 |
The 12-month price targets, analyzed by analysts, offer insights with an average target of $68.15, a high estimate of $75.00, and a low estimate of $60.00. Marking an increase of 12.05%, the current average surpasses the previous average price target of $60.82.
Investigating Analyst Ratings: An Elaborate Study
In examining recent analyst actions, we gain insights into how financial experts perceive Comerica. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Janet Lee | TD Cowen | Announces | Hold | $75.00 | - |
| Brandon King | Truist Securities | Raises | Hold | $70.00 | $68.00 |
| Dave Rochester | Cantor Fitzgerald | Announces | Neutral | $72.00 | - |
| David Chiaverini | Jefferies | Raises | Hold | $75.00 | $70.00 |
| David Chiaverini | Jefferies | Raises | Hold | $70.00 | $50.00 |
| Brandon King | Truist Securities | Raises | Hold | $68.00 | $61.00 |
| Peter Winter | DA Davidson | Raises | Neutral | $60.00 | $56.00 |
| Scott Siefers | Piper Sandler | Raises | Neutral | $65.00 | $60.00 |
| Terry McEvoy | Stephens & Co. | Raises | Equal-Weight | $68.00 | $61.00 |
| Christopher Mcgratty | Keefe, Bruyette & Woods | Raises | Outperform | $73.00 | $69.00 |
| Christopher Mcgratty | Keefe, Bruyette & Woods | Raises | Outperform | $69.00 | $68.00 |
| Benjamin Gerlinger | Citigroup | Raises | Neutral | $61.00 | $54.00 |
| Anthony Elian | JP Morgan | Raises | Underweight | $60.00 | $52.00 |
Key Insights:
- Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Comerica. This offers insight into analysts' perspectives on the current state of the company.
- Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Comerica compared to the broader market.
- Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Comerica's stock. This examination reveals shifts in analysts' expectations over time.
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Comerica's market position. Stay informed and make well-informed decisions with our Ratings Table.
Stay up to date on Comerica analyst ratings.
Unveiling the Story Behind Comerica
With assets of around $80 billion, Comerica is primarily a relationship-based commercial bank headquartered in Dallas. In addition to Texas, Comerica's other primary geographies are California and Michigan, with locations also in Arizona and Florida and select businesses operating in several other states as well as Canada and Mexico.
Key Indicators: Comerica's Financial Health
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3M period, Comerica showcased positive performance, achieving a revenue growth rate of 3.03% as of 30 June, 2025. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Comerica's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 22.03%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Comerica's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of 2.77%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Comerica's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.24%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Comerica's debt-to-equity ratio is below the industry average at 1.27, reflecting a lower dependency on debt financing and a more conservative financial approach.
The Core of Analyst Ratings: What Every Investor Should Know
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
